跳至主要内容
临床试验/TCTR20200827001
TCTR20200827001进行中(未招募)3 期

Efficacy and Safety of Benjakul Remedy Extract Capsule in Primary Osteoarthritis versus Naproxen (Clinical Trial Phase III)

Faculty of Medicine, Thammasat University0 个研究点目标入组 350 人开始时间: 2020年8月27日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
350

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Diagnosis of idiopathic OA knee according to clinical criteria of American College of Rheumatology
  • Knee pain + at least 3 of 6:
  • o Age > 50 years
  • o morning stiffness< 30 minutes
  • o bony tenderness
  • o bony enlargement
  • o no palpable warmth
  • 2. Pain score according to numerical rating scale (while standing) not less than 3
  • 3. Willing to participate

排除标准

  • 1 History of hypesensitivity herbal and naproxen
  • 2 History of lower extremity surgery within 6 months prior to screening
  • 3 Treatment with other drugs potentially affecting bone or cartilage metabolism such as
  • o Chronic systematic corticosteroids
  • o Glucosamine or chondroitin sulphate within 15 day prior to screening
  • o Hyaluronate injection into the index knee within 6 months prior to screening
  • o Diacerin treatment within 12 months prior to screening
  • 4 Chronic kidney disease eGFR < 60 ml min 1 73 m2
  • 5 History of drug or alcohol abuse
  • 6 history of peptic ulcer disease, hepatic or renal impairment AST or ALT above normal range GFR below 30 ml min 1 73 m2

研究者

发起方
Faculty of Medicine&#44; Thammasat University

相似试验